BCHE and dementia: However, the optimal anti-dementia drug that modifies the core symptoms of dementia has repeatedly failed to develop.[4] Currently, only 4 drugs, including 3 cholinesterase inhibitors and memantine, are approved for the treatment of dementia by the U.S. Food and Drug Administration, and they only have the effect of short-term symptom relief and delay disease progression.[4]